AXON - A Deep Dive Into Axovant's Parkinson's Gene Therapy
The purpose of this article is to take an in-depth look at Axovant Sciences' (AXON) Parkinson's gene therapy which was briefly touched on in my previous article.
Parkinson's disease
Parkinson’s is a chronic, progressive and debilitating neurodegenerative resulting in the loss of neurons in the midbrain that produce the neurotransmitter dopamine. Declining levels of dopamine in this region of the brain, the putamen, leads to the motor symptoms associated with Parkinson’s, including tremors, slow movement or loss of movement, rigidity, and postural instability.
There are currently no therapies that effectively slow or